CD56 polysialylation promotes the tumorigenesis and progression via the Hedgehog and Wnt/β-catenin signaling pathways in clear cell renal cell carcinoma

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2017)Molecular classification of renal cell carcinoma and its implication in future clinical practice Kidney Cancer (Clifton, Va) 1 3-13

[3] Siegel RL(2013)Kidney cancer: characterizing late recurrence of renal cell carcinoma Nat Rev Urol 10 687-689

[4] Laversanne M(2019)Molecular-targeted therapy in advanced renal cell carcinoma based on pharmacokinetics, pharmacodynamics and pharmacogenetics: a proposed strategy Int J Urol 26 48-56

[5] Soerjomataram I(2011)The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling EMBO Mol Med 3 480-494

[6] Jemal A(2021)Spatiotemporal processing of neural cell adhesion molecules 1 and 2 by BACE1 in vivo J Biol Chem 296 1852-1864

[7] Casuscelli J(2004)Distinct roles of different neural cell adhesion molecule (NCAM) isoforms in synaptic maturation revealed by analysis of NCAM 180 kDa isoform-deficient mice J Neurosci 24 78-764

[8] Vano YA(2022)The different prognostic significance of polysialic acid and CD56 expression in tumor cells and lymphocytes identified in breast cancer NPJ Breast Cancer 8 757-1204

[9] Fridman WH(2020)Insulinoma-associated protein 1 (INSM1) is a better marker for the diagnosis and prognosis estimation of small cell lung carcinoma than neuroendocrine phenotype markers such as chromogranin A, synaptophysin, and CD56 Am J Surg Pathol 44 1192-37

[10] Hsieh JJ(2020)Upregulation of neural cell adhesion molecule 1 (NCAM1) by hsa-miR-141-3p suppresses ameloblastoma cell migration Med Sci Monit 26 36-17179

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2017)Molecular classification of renal cell carcinoma and its implication in future clinical practice Kidney Cancer (Clifton, Va) 1 3-13

[3] Siegel RL(2013)Kidney cancer: characterizing late recurrence of renal cell carcinoma Nat Rev Urol 10 687-689

[4] Laversanne M(2019)Molecular-targeted therapy in advanced renal cell carcinoma based on pharmacokinetics, pharmacodynamics and pharmacogenetics: a proposed strategy Int J Urol 26 48-56

[5] Soerjomataram I(2011)The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling EMBO Mol Med 3 480-494

[6] Jemal A(2021)Spatiotemporal processing of neural cell adhesion molecules 1 and 2 by BACE1 in vivo J Biol Chem 296 1852-1864

[7] Casuscelli J(2004)Distinct roles of different neural cell adhesion molecule (NCAM) isoforms in synaptic maturation revealed by analysis of NCAM 180 kDa isoform-deficient mice J Neurosci 24 78-764

[8] Vano YA(2022)The different prognostic significance of polysialic acid and CD56 expression in tumor cells and lymphocytes identified in breast cancer NPJ Breast Cancer 8 757-1204

[9] Fridman WH(2020)Insulinoma-associated protein 1 (INSM1) is a better marker for the diagnosis and prognosis estimation of small cell lung carcinoma than neuroendocrine phenotype markers such as chromogranin A, synaptophysin, and CD56 Am J Surg Pathol 44 1192-37

[10] Hsieh JJ(2020)Upregulation of neural cell adhesion molecule 1 (NCAM1) by hsa-miR-141-3p suppresses ameloblastoma cell migration Med Sci Monit 26 36-17179